Screening of the antimycobacterial activity of novel lipophilic agents by the modified broth based method
  by Zandhaghighi, Mehdi et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 3 (2016) 1–5 
Contents lists available at ScienceDirect 
Journal of Clinical Tuberculosis and Other 
Mycobacterial Diseases 
journal homepage: www.elsevier.com/locate/jctube 
Screening of the antimycobacterial activity of novel lipophilic agents 
by the modiﬁed broth based method 
Mehdi Zandhaghighi a , Kiarash Ghazvini a , Zahra Meshkat a , Seyed Abdolrahim Rezaee a , 
Mohammad Derakhshan a , Saman Soleimanpour a , Farzin Hadizadeh b , ∗
a Antimicrobial Resistance Research Center & Department of Medical Bacteriology and Virology, Bu-Ali Research Institute & Ghaem University Hospital, 
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 
b Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 
a r t i c l e i n f o 
Article history: 
Received 30 July 2015 
Revised 29 December 2015 
Accepted 25 January 2016 
Keywords: 
Antitubercular agents 
Dihydropyridines 
Preclinical drug evaluation 
Microbial sensitivity tests 
a b s t r a c t 
Most of the introduced susceptibility methods of Mycobacterium tuberculosis have some disadvantages 
for screening. Therefore, the selection of susceptibility assay for evaluating candidate agents must be 
determined case by case. In this study, we evaluated the validity of a modiﬁed broth dilution-based assay 
in comparison to the gold standard proportional method for microbial sensitivity test of new lipophilic 
compounds candidate as antitubercular agents. The in-vitro susceptibilities of 114 M. tuberculosis strains 
were separately tested against isoniazid and two lipophilic antitubercular agents (derivative of dihy- 
dropyridines) by employing the standard proportional method and a modiﬁed broth dilution-based assay. 
The results for isoniazid testing showed 100% concordance for sensitivity, speciﬁcity and reproducibility. 
In the case of microbial sensitivity test of lipophilic compounds, comparison of the results obtained 
from these two methods indicates a signiﬁcant superiority of the modiﬁed method over the standard 
method. Considering the other advantages of this modiﬁed method, we concluded that this modiﬁed 
broth dilution-based assay could be utilized effectively for the susceptibility testing of new lipophilic 
compounds candidate as antitubercular agents. 
© 2016 Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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2. Introduction 
Emergence of drug-resistant tuberculosis represents an in-
reasingly major health problem worldwide. Globally in 2014,
80 thousand people developed multidrug-resistant tuberculosis
MDR-TB), and 123 thousand deaths from MDR-TB were detected
nd reported. Therefore, new, effective and well-tolerated treat-
ents for tuberculosis are needed to end the global tuberculosis
pidemic [1] Over the past few decades, scientists have syn-
hesized several new drugs, and derivatives of old drugs, in an
ttempt to ﬁnd new treatments for tuberculosis [2,3] . In this way,
ne of the most important steps in the preclinical drug evaluation
f new antitubercular agents is the susceptibility screening of
ycobacterium tuberculosis [4,5] . 
In the 1960s, Canetti et al., described the ﬁrst standard drug
usceptibility test method for M. tuberculosis , which performed on∗ Corresponding author. Tel.: + 98 511 8823255 65; fax: + 98 511 8823251. 
E-mail address: hadizadehf@mums.ac.ir (F. Hadizadeh). 
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405-5794/© 2016 Published by Elsevier Ltd. This is an open access article under the CCöwenstein–Jensen (L–J) medium with and without the drugs to
e tested [6] . Although many laboratories still use this method,
everal alternative drug susceptibility testing (DST) methods have
een introduced, each with advantages and disadvantages [7] . Us-
ng an egg-based L–J medium for DST requires heat for inspis-
ations (80–85 °C for 45 min); therefore, it cannot evaluate heat-
abile substances [8–10] . The other disadvantage of this method is
ome loss of drug activity as a result of binding to the egg proteins
10,11] . The agar-based method (Middlebrook 7H10 agar) has simi-
ar disadvantages, showing a reduction of drug activity as a result
f binding to the agar [11] . Although the automated liquid medium
ST methods (BACTEC 460TB, MGIT 960 system) eliminate these
roblems, they require an automated system that is expensive and
ot available in many less-equipped laboratories, which has inhib-
ted their widespread implementation [7,12,13] . 
Imani Fooladi et al . , by combining the two abovementioned
ethods (Middlebrook 7H9 broth, L–J medium), suggested a mod-
ﬁed broth macro-dilution-based method for the drug susceptibil-
ty testing of M. tuberculosis against new heat-labile antitubercular
gents. They only evaluated this method on M. tuberculosis strain
37Rv and a few other strains [8] . BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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m  The selection of a suitable screening assay for the microbial
sensitivity testing of new antimycobacterial candidate drugs re-
quires the consideration of several parameters including: sensitiv-
ity, expensiveness, radiometric disposal, need for high technology,
high throughput, drug stability in culture mediums, potential to
detect the precise minimum inhibitory concentration (MIC) as well
as percent of growth inhibition, and rapidity. However, most of the
introduced methods have some disadvantages for screening. There-
fore, the selection of an antimycobacterial susceptibility assay for
evaluating candidate drugs must be determined case by case. 
While determining the inhibitory activities of some newly
synthesized lipophilic antituberculosis drugs (derivative of dihy-
dropyridines) against M. tuberculosis , [14] we initially carried out
susceptibility testing by the proportional method on L–J medium.
Surprisingly, no inhibition was observed. A review of the literature
suggested that the inactivation of drug substances may occur due
to interference with the L–J medium [10,11] . 
This study aimed to analyze the performance of a new mod-
iﬁed broth-based method for the MIC-determining of lipophilic
molecules, in comparison to the standard method on L–J medium.
The susceptibilities of 114 M. tuberculosis strains were evaluated
against isoniazid and two lipophilic antituberculosis drugs (deriva-
tive of dihydropyridines) employing both methods and the concor-
dance between them was calculated. 
2. Materials and methods 
In-vitro mycobacterium susceptibility tests were carried out by
two different methods: the proportional method on L–J medium
and modiﬁed broth macro-dilution assay. 
2.1. Bacterial strains and inoculums 
M. tuberculosis H37Rv (American-type culture collection 27294)
was the standard strain, and 113 isolates (pulmonary and extra
pulmonary) from patients referred to the regional reference labo-
ratory of tuberculosis in Mashhad, Iran were included in this study.
All isolates were identiﬁed as M. tuberculosis by Ziehl–Neelsen
staining, conventional biochemical and phenotyping methods and
polymerase chain reaction (PCR). All isolates were stored in Mid-
dlebrook 7H9 broth, containing 10% glycerol at −20 °C. Substantially
frozen stocks were subcultured on L–J mediums (Merck, Germany)
and incubated for 4 weeks (cells were in the exponential phase
of growth), and then bacterial suspensions corresponding to 1 Mc-
Farland turbidity were prepared in Middlebrook 7H9 broth from
fresh colonies. Final concentrations of 3 × 10 7 CFU/ml and 3 × 10 5 
CFU/ml of each isolate were prepared by adding Middlebrook 7H9
(inoculums 10 −1 , 10 −3 ). 
2.2. Drug preparation 
Stock solutions of isoniazid (Sigma Chemical Co.) and two di-
hydropyridine derivatives were prepared – the isoniazid in deion-
ized water and the lipophilic compounds in dimethyl sulfoxide
(DMSO) – and sterilized by passage through a syringe ﬁlter (BIOFIL,
0.22 μm). The ﬁnal concentrations in the L–J medium prior to
testing were 0.2, 1, 2 μg/ml for isoniazid, and 1, 2, 4, 8, 16, 32,
64 μg/ml for the lipophilic compounds. To assure a statistically ac-
curate comparison between the two methods, the inoculums, stock
solutions and ﬁnal concentrations in the 7H9 broth were the same
as in the L–J medium. In this study, isoniazid was selected as
the reference drug because many studies have shown that it is
the best indicator for antitubercular susceptibility method evalu-
ation, compared to other antitubercular drugs, and the difference
in MICs detected by the broth and L–J medium was minimal for
isoniazid [15] . .3. Susceptibility test by standard method on L–J medium 
Susceptibility testing against isoniazid and the lipophilic com-
ounds was performed on L–J (Merck, Germany) medium, as de-
cribed by Canetti et al. in the regional reference laboratory of
uberculosis, Mashhad, Iran. Brieﬂy, equal amounts of two differ-
nt dilutions (1:10 and 1:100) of a standardized inoculum (turbid-
ty equal to the 1 McFarland standard) were inoculated onto L–J
edium with and without the drugs to be tested. After 28 to 42
ays incubation, resistance percentage for this drug was calculated
y dividing the total number of colony-forming units (CFU) on the
rug- containing medium to the total number of colonies growing
n the drug-free medium. A 1% standard cut-off value was used
or the interpretation of resistance. Therefore, a culture with a re-
istance rate of less than 1% was considered susceptible to that
articular drug at that concentration, while a culture with a re-
istance rate greater than or equal to 1% was considered resistant
o that particular drug [6] . 
.4. Evaluation of anti-mycobacterial activity by modiﬁed broth 
ilution-based method 
The modiﬁed method was performed as described by Imani
ooladi et al. [8] . In brief, Middlebrook 7H9 (FLUKA chemie) broth
as prepared and enriched with 10% ADC (bovine albumin fraction
, dextrose, catalase), and Tween80 (0.05%, v/v). 
For each strain, two sets of test tubes were prepared (A, B).
ach set of test tubes consisted of: (a) test tubes contained 10 0 0 μl
f the Middlebrook 7H9 broth, with serial dilutions of these two
ipophilic compounds, which had been prepared freshly; (b) a
rug-free control tube contained 10 0 0 μl of the Middlebrook 7H9
roth with no additive; (c) a solvent control tube, which the test
edium was supplemented with DMSO at the highest concentra-
ion used in this study (4%, v/v); and (d) Middlebrook 7H9 broths
ontaining 0.2, 1 and 2 μg/ml of isoniazid. Then, 100 μl of inocu-
ums (10 −1 , 10 −3 ) was added to the tubes of each set (A, B), re-
pectively. 
After 7 days of incubation at 37 °C, 100 μl of each tube was
noculated on L–J medium (without any drug), and incubated at
7 °C for 28 days. After 28 days, visible colonies were interpreted
s bacterial growth; if there were no colonies, the L–J medium was
nspected for further two weeks, and the results were reported af-
er 42 days [6] . Colonies on each tube of the L–J medium were
ounted, and the number of colonies in the test tubes (transferred
rom drug-containing tubes) was compared with the number of
olonies in the control tubes (transferred from drug-free tubes),
nd the percent of growth inhibition was calculated with the fol-
owing formula: 
ercent of inhibition 
= (1 − ( colony count of test sample / 
colony count of drug − free control )) × 100 
The minimum bactericidal concentration (MBC) was deﬁned as
he lowest drug concentration that totally prevents colony forma-
ion, and minimum inhibitory concentration (MIC 90 ) was deﬁned
s the lowest drug concentration that inhibits formation of more
han 90% of colonies (reducing the bacterial load by 1 log unit), in
omparison to the drug-free control. 
Resistance was expressed as a growth of 1% or more of the bac-
erial population on media containing the breakpoint concentra-
ion of isoniazid; the breakpoint value was deﬁned as 0.2 μg/ml
9,13,16,17] . Data were analyzed using SPSS (version 16.0.0, 2007,
PSS Inc). Using Cohen’s kappa coeﬃcient, the agreement between
he two methods was measured. Cohen’s kappa coeﬃcient is the
ost commonly used statistic to assess the degree of agreement
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Table 1 
Susceptibilities of M. tuberculosis strains against isoniazid at breakpoint concentration (0.2 μg/ml), de- 
termined by the proportional method on L–J and modiﬁed broth-based methods. 
Strains Method 
Proportional method on L–J a Modiﬁed broth based 
H37Rv The H37Rv was susceptible The H37Rv was susceptible 
77 susceptible strains All 77 isolates were susceptible All 77 isolates were susceptible 
36 resistant strains All 36 isolates were resistant All 36 isolates were resistant 
a: Lowenstein–Jensen, b: susceptible, c: resistant 
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s  etween two tests. A calculated kappa equal to 1 indicates perfect
greement, whereas a kappa of 0 indicates agreement equivalent to
hance [13,16,18] . P value < 0.05 was considered to be statistically
igniﬁcant. All antitubercular assays were performed in duplicate,
nd the mean values of inhibition were indicated. 
. Results 
Initially, susceptibilities of all strains against isoniazid were
easured by the proportional method on L–J medium. Seventy-
even isolates showed no growth, which was interpreted as sus-
eptible (MBC ≤ 0.2 μg/ml), and 36 isolates showed more than
% growth at concentration of 0.2 μg/ml, which was interpreted
s resistant against isoniazid. The M. tuberculosis strain H37Rv also
dentiﬁed as susceptible. Then, the susceptibilities of all strains
ere tested against isoniazid by the modiﬁed broth-based method.
ll 77 susceptible strains, as well as the H37Rv strain, were totally
nhibited by isoniazid at concentration of 0.2 μg/ml, and all resis-
ance strains showed more than 1% growth (2–21% growth) by this
ethod, which was interpreted as resistance (see Table 1 ). 
The degree of concordance between two methods was eval-
ated by calculating the kappa value. The indicator kappa value
as κ =1, which allows us to assert that there was a perfect
oncordance between both methods. There was 100% concordance
etween the modiﬁed broth-based method and the proportional
ethod in the determination of MIC 90 and MBC of isoniazid for
usceptible strains. In the case of resistant strains, there was also
00% concordance between the two methods in the detection of
esistant strains, based on the breakpoint value (0.2 μg/ml); al-
hough, some MIC 90 s obtained by modiﬁed broth were one-fold
ilution lower than MIC 90 s obtained with the standard method. 
The susceptibilities of all strains against lipophilic compounds
ere measured by two methods. Using the standard method with
–J medium, no inhibitory activities were detected against all clini-
al isolates and the H37Rv strain, at all concentrations. In contrast,
hen using the modiﬁed broth-based method, all clinical isolates
nd the H37Rv strain showed signiﬁcant levels of inhibition (11–
00% for the susceptible group, and 0–98% for the resistant group)
y different concentrations of lipophilic compounds. Inhibition per-
ent of M. tuberculosis isolates and H37Rv at different concentra-
ions of lipophilic compound by modiﬁed method are shown in
able 2. Table 2 
Comparison between inhibition of M. tuberculosis isolates at different con
Strains Method Range of inhibition 
1 mg/mL 2 mg/mL 4 m
77 susceptible L–J a 0 b 0 0 
Modiﬁed broth 49% 57.5% 64.5
36 resistant L–J 0 0 0 
Modiﬁed broth 24.5% 37% 51%
a Lowenstein–Jensen 
b No inhibitions To insure that the solvent had no effect on bacterial growth, a
olvent control was prepared and the same inoculums used in the
xperiment were utilized; no inhibition was observed. 
. Discussion 
Due to the interest of scientists in developing new antituber-
ular agents, it is necessary to have a screening assay to evalu-
te the mycobacterium inhibitory activity of new drugs, especially
f lipophilic agents are to be tested, as they tend toward inactiva-
ion in L–J mediums [10] . Preferred susceptibility methods should
e inexpensive, practical, use appropriate mediums for drug stabil-
ty, be able to determine precise MIC as well as percent of growth
nhibition, and provide reliable results compared to the standard
ethod. 
In this study, we calculated the sensitivity (ability to detect
rue resistance), speciﬁcity (ability to detect true susceptibility)
nd reproducibility (agreement between duplicate cultures) of
he modiﬁed broth dilution method in comparison to the gold
tandard proportional L–J medium. The results for isoniazid testing
gainst 113 isolates and the H37Rv strain showed 100% concor-
ance for sensitivity, speciﬁcity and reproducibility. The calculated
appa coeﬃcient was one ( p = 0.0 0 0). 
The facts that the difference between MICs detected by broth
nd L–J medium was minimal for isoniazid [15] , involvement of
 large sample size, and showed 100% concordance in susceptibil-
ty testing; suggested that the results of the modiﬁed broth-based
ethod were completely conﬁrmed by the L–J method and found
o be a reliable method for susceptibility screening of M. tuberculo-
is . In addition, the lipophilic compounds tested in this study had
o inhibitory activities against any strains of M. tuberculosis on the
–J medium; though, they showed different antitubercular activity
0–100%) with the modiﬁed broth-based method (see Table 2 ). 
Considering the results obtained by this modiﬁed method and
ailure of standard method using L–J medium to detect inhibitory
ctivities of the lipophilic compounds, it could be assumed that
he cause of failure is due to interference of the L–J medium
omponents with these drugs. Also it can be concluded that this
odiﬁed broth based method is superior and supply an ideal
nvironment for lipophilic compounds to do their anti-
ycobacterial activity without interference. 
Although antitubercular DSTs are carried out mainly using the
tandard proportional method on L–J medium and Middlebrookcentrations of lipophilic compound by two methods. 
g/mL 8 mg/mL 16 mg/mL 32 mg/mL 64 mg/mL 
0 0 0 0 
% 73% 79% 85% 93% 
0 0 0 0 
 57.5% 63% 76% 83.5% 
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 7H10 agar, they have many disadvantages. In addition to the in-
activation of heat-labile drugs [8,10] , reduction of drug activity can
occur because of (a) binding of the drug to the agar (agar-based
mediums), or proteins and phosphate of egg (egg-based mediums)
[10,11,19,20] ; (b) prolonged incubation time, which potentially re-
duces the potency of certain antimicrobials; and (c) less contact
of organisms with appropriate concentrations of antimycobacterial
substances on solid media [8,9] . Although, the two lipophilic com-
pounds (derivative of dihydropyridines) tested in this study have
relative heat stability, the above-mentioned disadvantages of L–
J medium (all or in part) might explain their inactivation in the
standard method. 
The cell wall of mycobacteria is rich in lipids [21,22] ; therefore,
most antitubercular agents are lipophilic [23–27] , and screening of
these compounds for antitubercular activities requires compatible
methods. As such compounds have a major binding aﬃnity to egg
components; the inactivation of lipophilic compounds in an egg-
based medium could have adverse consequences on microbial sen-
sitivity testing. However, further investigations are needed to de-
termine the precise mechanisms of inactivation of these lipophilic
compounds in an L–J medium. 
Recently, broth-based DSTs have been recommended for clin-
ical and research tests by the US Food and Drug Administration
(FDA) and the World Health Organization (WHO), using commer-
cial broth-based systems (BACTEC 460TB, MGIT 960 system) [ 17 ,
28 ]. Although these methods are rapid and improve the repro-
ducibility of MIC determination [29] , their high cost and high
technological needs inhibit their widespread implementation, es-
pecially in less-equipped laboratories [7,12,30] . 
Imani Fooladi et al. combined the two aforementioned methods
(Middlebrook 7H9 broth, L–J medium) and suggested the modiﬁed
broth dilution method for the DST of M. tuberculosis against heat-
labile anti-TB drugs. They only evaluated this method on M. tuber-
culosis strain H37Rv and a few other strains [8] . Since the study
size was small, it is necessary to evaluate this method in a larger
population to come to a more accurate and acceptable conclusion.
To our knowledge, a large-scale evaluation of this modiﬁed method
has not been assayed. The present study utilized a considerable
number of strains, which were tested to determine the validity
of this modiﬁed method. The results showed that this modiﬁed
method could ease susceptibility testing of M. tuberculosis against
new lipophilic antitubercular agents in less-equipped laboratories,
especially because it requires no high technology or high cost.
However, there are some limitations, such as a 5–7 week waiting
period for ﬁnal results, a requirement for two different mediums
and greater amounts of manipulation, which can be hazardous.
This modiﬁed assay proved to be an ideal method for preclinical
susceptibility testing and determination of the exact MBCs as well
as percent of inhibition of new antitubercular agents, especially
heat-labile or/and lipophilic compounds. Although, utilization of
this modiﬁed method for the susceptibility testing of ﬁrst-line anti-
B drugs (e.g. rifampicin, which experiences some inactivation in
L–J medium) may inhibit partial inactivation of the drug by the
culture medium; however, before this method can be performed
for routine drug susceptibility, further investigations are needed. 
The complete agreement between the results obtained from the
modiﬁed broth-based method and the proportional L–J medium in
the susceptibility testing of 114 strains of M. tuberculosis against
isoniazid suggests that this modiﬁed method is reliable and has
validity, compared with the gold standard L–J method. 
Considering the failure of the standard method for the suscep-
tibility testing of lipophilic antitubercular drugs, and the reliable
results obtained using the modiﬁed broth-based method, we con-
clude that performance of the modiﬁed method can diminish the
interference effect of an L–J medium on lipophilic antitubercular
drugs. The modiﬁed broth-based method is sensitive, inexpensive,on radiometric, and offers the potential for screening without
igh technology instrumentation. Therefore, this modiﬁed method
ould be recommended for the susceptibility screening of M. tuber-
ulosis against not only heat-labile drugs as mentioned by Imani et
l. [10] but also lipophilic compounds candidate as antitubercular
gents. 
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